 BEDMER, N.J., April 27, 2021 GLOBE NEWSWIRE -- Matinas BioPharma Holdings, Inc. NYSE AMER: MTNB, a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal LNC delivery platform, today announced that the Company will host a conference call and live audio webcast on Monday, May 10, 2021 at 8:00 a.m. ET to discuss operational and financial results for the first quarter ended March 31, 2021. 